Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CNR2 contributors: mct - updated : 15-12-2021
HGNC name cannabinoid receptor 2 (macrophage)
HGNC id 2160
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
seven transmembrane segments (7TM) receptor, hematopoietic
HOMOLOGY
interspecies homolog to murine Cnr2
Homologene
FAMILY family 1 of G protein coupled receptor
CATEGORY protooncogene , receptor membrane G
SUBCELLULAR LOCALIZATION     plasma membrane
    intracellular
intracellular,cytoplasm,organelle,endoplasmic reticulum
basic FUNCTION
  • inhibiting adenylate cyclase
  • putatively involved in the initiation of cell maturation
  • playing an essential role for the maintenance of normal bone mass by osteoblastic and osteoclastic signaling
  • CNR2, but not CNR1, regulates embryonic HSC (Hematopoietic Stem Cell) development
  • CNR2-signaling optimizes the production, expansion, and migration of embryonic HSCs by modulating multiple downstream signaling pathways
  • major receptor of endocannabinoid system that is crucial for bone mass homeostasis
  • osteogenic differentiation induced by CNR2 signaling activation involves autophagy induction
  • CNR2 activation can induce neurons proliferation and survival through activation of ERK and MAPK14 signaling pathways
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • upregulating nine genes involved in cytokine synthesis, regulation of transcription, cell differentiation
  • activation of CNR2 could promote the intracellular degradation of HMGB1 via the autophagy-lysosome pathway in macrophage
  • cell & other
    REGULATION
    activated by 2-arachidonoylglycerol
    elevated endogenous levels of endocannabinoids
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional       loss of function
    combined deficiency of the CNR1 and CNR2 receptors protects against age-related bone loss by osteoclast inhibition
    Susceptibility
  • to ostoporosis (low hip BMD)
  • to immune thrombocytopenic purpura
  • Variant & Polymorphism SNP
  • increasing the risk of osteoporosis
  • significant overrepresentation of the RR genotype and of the R allele was observed only for the chronic form of immune thrombocytopenic purpura children
  • Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    osteoarticularbone 
    molecular target for the diagnosis and treatment of osteoporosis and other bone diseases (antagonists of CNR2)
    metabolismlipid 
    pharmacological manipulation of CB2R may provide therapeutic possibilities to treat metabolic diseases associated with lipid dysregulation
    ANIMAL & CELL MODELS
  • extensive cardiomyocyte loss and confluent scar formation were found in Cnr2-/- mice accompanied by significantly increased apoptosis and left ventricular dysfunction when compared with Cnr2 +/+ mice